These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 25495497)
1. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. Neunert C; Noroozi N; Norman G; Buchanan GR; Goy J; Nazi I; Kelton JG; Arnold DM J Thromb Haemost; 2015 Mar; 13(3):457-64. PubMed ID: 25495497 [TBL] [Abstract][Full Text] [Related]
3. Bleeding complications in immune thrombocytopenia. Arnold DM Hematology Am Soc Hematol Educ Program; 2015; 2015():237-42. PubMed ID: 26637728 [TBL] [Abstract][Full Text] [Related]
4. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort. Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B; Jonsson OG; Elinder G; Wesenberg F; Henter JI; J Pediatr; 2003 Sep; 143(3):302-7. PubMed ID: 14517509 [TBL] [Abstract][Full Text] [Related]
5. Evaluating bleeding severity in immune thrombocytopenia (ITP). Neunert CE Ann Hematol; 2010 Jul; 89 Suppl 1():47-50. PubMed ID: 20309688 [TBL] [Abstract][Full Text] [Related]
6. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life. Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults. Piel-Julian ML; Mahévas M; Germain J; Languille L; Comont T; Lapeyre-Mestre M; Payrastre B; Beyne-Rauzy O; Michel M; Godeau B; Adoue D; Moulis G; J Thromb Haemost; 2018 Sep; 16(9):1830-1842. PubMed ID: 29978544 [TBL] [Abstract][Full Text] [Related]
8. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. Medeiros D; Buchanan GR J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712 [TBL] [Abstract][Full Text] [Related]
9. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia. Zhou F; Xu Y; Zhang Z; Wu X; Jin R J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan. Hato T; Shimada N; Kurata Y; Kuwana M; Fujimura K; Kashiwagi H; Takafuta T; Murata M; Tomiyama Y Blood Adv; 2020 Apr; 4(8):1648-1655. PubMed ID: 32320469 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age. Zhao P; Hou M; Liu Y; Liu HX; Huang RB; Yao HX; Niu T; Peng J; Jiang M; Han YQ; Hu JD; Zhou H; Zhou ZP; Qiu L; Zhang LS; Wang X; Wang HQ; Feng R; Yang LH; Ma LM; Wang SQ; Kong PY; Wang WS; Sun HP; Sun J; Zhou HB; Zhu TN; Wang LR; Zhang JY; Huang QS; Liu X; Fu HX; Li YY; Wang QF; Jiang Q; Jiang H; Lu J; Zhang XH Platelets; 2021 Jul; 32(5):633-641. PubMed ID: 32614630 [TBL] [Abstract][Full Text] [Related]
13. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Psaila B; Petrovic A; Page LK; Menell J; Schonholz M; Bussel JB Blood; 2009 Nov; 114(23):4777-83. PubMed ID: 19767509 [TBL] [Abstract][Full Text] [Related]
14. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Cohen YC; Djulbegovic B; Shamai-Lubovitz O; Mozes B Arch Intern Med; 2000 Jun; 160(11):1630-8. PubMed ID: 10847256 [TBL] [Abstract][Full Text] [Related]
15. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk. McDonnell A; Bride KL; Lim D; Paessler M; Witmer CM; Lambert MP Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921855 [TBL] [Abstract][Full Text] [Related]
16. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients. Tsuda H; Tsuji T; Tsuji M; Yamasaki H Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759 [TBL] [Abstract][Full Text] [Related]
17. Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding. Grimaldi D; Canouï-Poitrine F; Croisille L; Lee K; Roudot-Thoraval F; Languille L; Khellaf M; Michel M; Godeau B; Bierling P Ann Hematol; 2014 Feb; 93(2):309-15. PubMed ID: 23912633 [TBL] [Abstract][Full Text] [Related]
18. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura. Neunert CE; Buchanan GR; Blanchette V; Barnard D; Young NL; Curtis C; Klaassen RJ Pediatr Blood Cancer; 2009 Oct; 53(4):652-4. PubMed ID: 19492316 [TBL] [Abstract][Full Text] [Related]
19. Thrombosis in patients with primary chronic immune thrombocytopenia. Nørgaard M Thromb Res; 2012 Oct; 130 Suppl 1():S74-5. PubMed ID: 23026671 [TBL] [Abstract][Full Text] [Related]
20. Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura. Chandra J; Ravi R; Singh V; Narayan S; Sharma S; Dutta AK Hematology; 2006 Apr; 11(2):131-3. PubMed ID: 16753855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]